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Abstract Conversions of (Z,E)- and (E,E)-isomers of linoleic
acid 13- and 9-hydroperoxides with flax and maize allene oxide
synthase were studied. All-(E) but not (Z,E) hydroperoxides
readily undergo cyclization via allene oxides into trans-
cyclopentenones. These results suggest that double bond
geometry dramatically affects the formation of pericyclic
pentadienyl cation intermediate and thus the capability of
18:2-allene oxides to undergo electrocyclization into cyclopente-
nones.
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1. Introduction
Except cyclooxygenase pathway, widespread in mammals,
there is another route to cyclopentane fatty acid derivatives in
nature. Allene oxide fatty acids, short-lived products of allene
oxide synthase (AOS, EC 4.2.1.92), are precursors of cyclo-
pentenones (15Z)-12-oxo-10,15-phytodienoic acid (12-oxo-
PDA) in plants [1^5] and preclavulone A in corals [6,7]. An-
nulation of allene oxides into cyclopentenones occurs either
spontaneously [3,7] or enzymatically [4,5]. AOSs utilize di¡er-
ent fatty acid hydroperoxides [8^10]. However, not all of al-
lene oxides undergo conversion into cyclopentenones [8^10].
Annulation is strongly dependent on the presence of a double
bond in the L,Q-position besides with oxirane of allene oxide
[8^11]. Allene oxide cyclase (EC 5.3.99.6), a plant enzyme,
catalyzing annulation, speci¢cally utilizes only (9Z,13S,15Z)-
12,13-epoxy-9,11,15-octadecatrienoic acid [11,12].
12-Oxo-PDA is an important physiologically active com-
pound and metabolic precursor of a newly acknowledged
plant hormone 7-iso-jasmonate. Increasing interest to these
important natural products led to some recent attempts to
¢nd a biosynthetic pathway from linoleic acid to 12-oxo-10-
phytoenoic acid, i.e. 15,16-dihydro analogue of 12-oxo-PDA
[13^16].
The present paper is concerned with AOS conversions of
all-(E) 9- and 13-HPODs. We found that allene oxides gen-
erated from these hydroperoxides are e¡ectively converted
into the novel cyclopentenone 10-oxo-11-phytoenoic acid
and 12-oxo-10-phytoenoic acid, respectively. The obtained re-
sults provide new insight into the mechanism of allene oxide
annulation.
2. Materials and methods
2.1. Preparation of fatty acid hydroperoxides
Racemic hydroperoxides, (9Z,11E,13R,S)-13-hydroperoxy-9,11-oc-
tadecadienoic acid {(9Z,11E)-13(R,S)-HPOD}; (9E,11E,13R,S)-13-
hydroperoxy-9,11-octadecadienoic acid {(9E,11E)-13(R,S)-HPOD},
(9R,S,10E,12Z)-9-hydroperoxy-10,12-octadecadienoic acid {(10E,
12Z)-9(R,S)-HPOD} and (9R,S,10E,12E)-9-hydroperoxy-10,12-octa-
decadienoic acid {(10E,12E)-9(R,S)-HPOD} were prepared as de-
scribed before [17] by autoxidation of linoleic acid. The resulting
mixture of racemic hydroperoxides, having Z,E- and E,E-double
bond geometry, was separated by normal phase HPLC (SP-HPLC).
Isomeric 9-HPODs were ¢nally separated by the reversed phase
HPLC. Chiral 13(S)-HPOD and 13(S)-HPOT were obtained by incu-
bations of linoleic and K-linolenic acids, respectively, with soybean
lipoxygenase (LOX). (6Z,9S,10E,12E)-9-hydroperoxy-6,10,12-octade-
cadienoic acid {9(S)-HPOT(Q)} was obtained by incubation of Q-lino-
lenic acid with tomato fruit LOX.
2.2. AOS preparation and incubations
Flaxseed acetone powder was prepared as described before [18,19].
AOS was extracted from 10 g of acetone powder with 150 ml of
100 mM phosphate bu¡er, pH 7.4 at 0‡C. Extract was centrifuged
at 9300Ug for 10 min. The supernatant was used as AOS solution for
incubations.
Maize AOS (2 mg protein) prepared as described before [5] was
suspended in 10 ml of 100 mM phosphate bu¡er, pH 6.7. Incubations
were performed at 0‡C for 20 min, starting with the addition of
30 Wmol of (9E,11E)-13-HPOD, (9Z,11E)-13-HPOD, (10E,12E)-9-
HPOD, or (10E,12Z)-9-HPOD in 100 Wl of ethanol.
2.3. Extraction and preliminary puri¢cation of products
Incubations were terminated by the addition of equal volumes of
methanol. Then the incubation mixture was acidi¢ed with 2 M HCl to
pH 3.5 and extracted with diethyl ether. Flaxseed AOS incubation
mixtures were diluted with four volumes of water before extraction.
Acidic lipids were separated and puri¢ed for further HPLC and GC-
MS analyses using the Supelclean LC-NH2 (3 ml) cartridges (Supelco,
Bellefonte, PA, USA) as described [20].
2.4. Analyses of products
Acidic fraction from NH2 cartridge was methylated with diazo-
methane. The resulting methyl esters were analyzed by GC-MS in
two di¡erent modes: either (1) full spectral scanning within m/z range
from 50 to 650, or (2) selected ion monitoring (SIM) of ions at m/z
152, 238, 308 and 382. Alternatively, the same samples were tri-
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methylsilylated after methylation. The TMS derivatives of methyl es-
ters were analyzed using the same two above described approaches.
Products were separated as free acids either by isocratic RP-HPLC
on a Macherey-Nagel Nucleosil 5 ODS column (250U4.6 mm), sol-
vent mixture acetonitrile-water-acetic acid (60:40:0.01, by volume),
£ow rate 1.5 ml/min. Non-polar products eluting before 13- or 9-
HODs were collected and subjected to diazomethane methylation.
Methods of hydrogenation, trimethylsilylation and alkaline isomeriza-
tion were described before [21].
Ultraviolet spectra were recorded with Hitachi U2000 spectropho-
tometer (Hitachi, Tokyo, Japan). Gas chromatography (GLC) analy-
ses with Hewlett-Packard model 5980 instrument (£ame ionization
detection) and gas chromatography-mass spectrometry (GC-MS)
analyses with Hewlett-Packard model 5970B GC-MS system were
performed as described before [20].
3. Results
3.1. Metabolism of HPODs by £ax and maize AOS
Summary products of incubations with £ax or maize AOS
were analyzed by RP-HPLC and GC-MS. Hydroxy acids
(HODs) belonged to the main metabolites of all four racemic
HPOD isomers. A large yield of HODs is, apparently, ex-
plained by non-enzymatic reduction of (R)-HPODs. As dem-
onstrated previously, £ax [22] and corn (Hamberg, M., un-
published observations) AOSs preferentially utilize (S)-
stereoisomers during incubations with (R,S)-HPODs.
HPLC analyses of extracts of all incubations with £axseed
AOS revealed the presence of some amount of endogenous 12-
oxo-10,15-PDA (RP-HPLC retention time 10.5 min), ultravio-
let and mass spectral data of which were identical to previ-
ously described [21]. All HPOD isomers were partly converted
into the corresponding K-ketols (RP-HPLC retention time ca.
11.5 min). Analyses of extracts of incubations with (9E,11E)-
13-HPOD and (10E,12E)-9-HPOD allowed to detect peaks I
and IV (respectively, RP-HPLC retention times ca. 14 and 15
min, for structures see Fig. 1), eluting before all-(E) 13- and 9-
HODs (RP-HPLC retention times ca. 15.5 and 16.7 min).
Products I and IV were collected for further analyses.
Product I (C-value 19.71) had the ultraviolet absorbance
maximum (EtOH) at 225 nm. The electron impact (70 eV)
mass spectral data for compound I (methyl ester) are pre-
sented in Table 1. The molecular mass (M at m/z 308) as
well as the fragmentation patterns (Table 1) fully correspond
to previously published mass spectral data for 12-oxo-10-phy-
toenoic acid [15,21].
Catalytic hydrogenation of product I (as methyl ester) over
PtO2 a¡orded compound II. Its mass spectral data are pre-
sented in Table 1. Although the molecular ion was not de-
tected, the observed spectral data suggest that compound II
has the structure of 12-oxo-phytonoic acid. These results dem-
onstrate that compound I has one double bond.
For the assignment of geometrical isomerism of compound
I we prepared authentic sample of 12-oxo-PDA, having cis
con¢guration of side chains. Part of this preparation was sub-
jected to mild alkali treatment, as described above. Both orig-
inal and isomerized samples of 12-oxo-PDA were subjected to
catalytic hydrogenation over PtO2. This enabled us to obtain
samples of cis- and trans-12-oxophytonoic acid (III and II,
respectively). Authentic sample of trans-12-oxophytonoic
acid had coinciding C-value (19.60) with hydrogenation prod-
uct (II) of metabolite I during GC-MS analyses. The second
isomer having cis con¢guration of side chains (III) had dis-
tinct C-value (19.85). Thus, AOS conversion of (9E,11E)-13-
HPOD a¡ords trans-12-oxo-10-phytoenoate (I).
Table 1
Mass spectra of the identi¢ed metabolites I and IV (as methyl esters) and products of their hydrogenation II and V, m/z (relative intensity, %)
Ion attribution Compounds
I II IV V
[M] 308 (4) 308 (2) 310 (1)
[M3MeO] 277 (17) 279 (2) 277 (8) 279 (3)
[M3C5H11+H] 238 (26) 240 (6)
[M3C5H11] 239 (3)
[M3C5H11+H3MeOH] 206 (23)
[M3C5H113MeOH] 207 (8)
[M3(CH2)5COOMe] 179 (13)
[M3(CH2)5COOMe3H] 178 (17)
[M3(CH2)6COOMe] 165 (12) 165 (4)
[M3C10H17O+H] 158 (3)
[M3(CH2)7COOMe+H] 152 (68) 154 (16)
[M3(CH2)7COOMe] 151 (39) 153 (14)
[M3(CH2)7COOMe3CO] 123 (9)
[C7H9O] 109 (52) 109 (15)
[C6H8O] 96 (100)
[C6H7O] 95 (86) 95 (100)
[C5H7O] 83 (100) 83 (100)
[C5H6O] 82 (59) 82 (31)
Fig. 1. The structural formulas of detected cyclopentenones I and
IV, products of their catalytic hydrogenation II and V and the cor-
responding cis isomers III and VI, prepared by hydrogenation of
(15Z)-12-oxo-10,15-phytodienoic and (6Z)-10-oxo-6,11-phytodienoic
acids, respectively.
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Incubation of (10E,12E)-9-HPOD with £ax or maize AOS
a¡orded, inter alia, compound IV (C-value 19.68), having the
ultraviolet absorbance maximum at 224 nm (in mobile phase
acetonitrile-water-acetic acid 60:40:0.01 by volume). The
mass spectral data for compound IV (methyl ester) are pre-
sented in Table 1. Along with M at m/z 308 spectrum pos-
sesses a characteristic prominent ion at m/z 152, generating
due loss of (CH2)7COOCH3, accompanied by one hydrogen
migration. The observed fragmentation patterns allow to as-
cribe the structure of 10-oxo-11-phytoenoic acid for product
IV.
Hydrogenation of product IV over PtO2 a¡orded com-
pound V, having a featureless ultraviolet spectrum. The elec-
tron impact mass spectral data for compound V are presented
in Table 1. The spectrum contains a molecular ion M at m/z
310 and fragment ions, inter alia, (M3(CH2)7COOCH3+H)
at m/z 154. The obtained results allow to identify compound
V as 10-oxo-phytonoic acid. Thus, metabolite IV has one
double bond.
For structural con¢rmation of compounds IV and V we
prepared an authentic sample of (6Z)-10-oxo-6,11-phytodi-
enoic acid by incubation of 9(S)-HPOT(Q) with maize AOS.
Part of the resulting cis-cyclopentenone was subjected to al-
kaline isomerization as described above. Both isomerized and
non-isomerized cyclopentenones were hydrogenated over
PtO2, a¡ording the authentic samples of trans- and cis-10-
oxophytonoic acid (V and VI, respectively). The authentic
sample of trans-10-oxophytonoic acid had an identical C-val-
ue (19.52) and MS data with hydrogenation product V of
metabolite V during GC-MS analyses. cis Isomer (VI) had a
distinct C-value (19.79). Thus, AOS conversion of (10E,12E)-
9-HPOD a¡ords trans-10-oxo-11-phytoenoic acid (IV).
3.2. Quanti¢cation of cyclopentenones by selected ion
monitoring (SIM) GC-MS
Only the SIM approach allowed to detect small amounts of
trans-cyclopentenones formed from (9Z,11E)-13-HPOD and
(10E,12Z)-9-HPOD. K-Ketols were by far predominant AOS
utilization products of these hydroperoxides. Cyclopentenone
to K-ketol ratios among the products of (9Z,11E)-13-HPOD
and (10E,12Z)-9-HPOD did not exceed 0.007 and 0.015, re-
spectively, as quanti¢ed by GLC with £ame ionization detec-
tion. All-(E) HPODs hydroperoxides a¡ord cyclopentenones
along with K-ketols. Cyclopentenone to K-ketol ratios were
0.44 for (9E,11E)-13-HPOD products and 0.40 for (10E,
12E)-9-HPOD products, as quanti¢ed by GLC with £ame
ionization detection.
For sensitive quanti¢cation of cyclopentenones formed dur-
ing hydroperoxide incubations with AOS we used the selected
ion monitoring (SIM) mode of GC-MS with tetracosanoic
acid methyl ester as the internal standard. Masses 152, 238
and 382 were monitored in SIM mode. Monitoring of masses
152 and 238 are speci¢c for 10-oxo-11-phytoenoic (IV) and
12-oxo-10-phytoenoic (I) acid methyl esters, respectively. Ion
382 corresponds to the molecular mass of methyl tetracosa-
noate.
SIM analysis of (9E,11E)-13-HPOD metabolites (as methyl
esters) allowed to detect 12-oxo-10-phytoenoic acid (I) (Table
2). Incubation of AOS with (9Z,11E)-13-HPOD a¡orded ca.
125 times smaller yield of compound I (Table 2).
Cyclopentenone IV was detected among the products of
(10E,12E)-9-HPOD conversion (Table 2). Hydroperoxide
Fig. 2. The proposed distinct mechanisms of pentadienyl cations
and cyclopentenones formation from (Z,E) and (E,E) HPODs via
allene oxides. R1 = ^CH2(CH2)3CH3 ; R2 = ^CH2(CH2)6COOH
(for 3-HPODs, their products and intermediates); R1 =
^CH2(CH2)6COOH; R2 = ^CH2(CH2)3CH3 (for 9-HPODs, their
products and intermediates).
Table 2
Quanti¢cation of cyclopentenones formed during the incubations of HPOD isomers with £ax and maize AOS
Substrate Ratio trans-cyclopentenone/internal standard
Incubations with £ax AOS Incubations with maize AOS
13-HPOD (E,E) 0.822 0.869
13-HPOD (Z,E) 0.00678 0.00664
9-HPOD (E,E) 1.526 6.10
9-HPOD (Z,E) 0.0570 0.296
Estimations of cyclopentenone/internal standard ratios were performed using GC-MS in selected ion monitoring (SIM) mode with tetracosanoic
acid methyl ester as an internal standard. Cyclopentenone I was quanti¢ed by integration of its peak detected by SIM at m/z 238, while com-
pound IV at m/z 152. Internal standard (methyl tetracosanoate) was quanti¢ed by integration of its peak at m/z 382.
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with ordinary double bond geometry, (10E,12Z)-9-HPOD,
was a much less e⁄cient cyclopentenone precursor. It a¡orded
only trans-cyclopentenone IV at a poor yield (Table 2).
4. Discussion
The obtained results demonstrate strong dependence of
18:2-allene oxides cyclization on the geometry of conjugated
double bond system. The inability of (Z,E) hydroperoxides
like (9Z,11E)-13-HPOD, lacking the ‘L,Q-double bond’, to
undergo AOS induced conversion into cyclopentenones was
noticed by many authors [3^5,8^12]. At the same time, there
are few exceptions. Previously Hamberg and Hughes [21] have
found that incubation of (9Z,11E)-13-HPOD with maize AOS
in presence of BSA and other albumins a¡ords trans-cyclo-
pentenone along with K-ketol. Similar observations on 18:2-
allene oxide cyclization in presence of BSA were recently re-
ported by Gardner [15] and Gundlach and Zenk [16]. Brash et
al. [23] observed trans-cyclopentenone formation after incuba-
tion of (5Z,9E,11Z,13E)-8-hydroxy-15-hydroperoxy-5,9,11,13-
eicosatetraenoic acid, also lacking a L,Q-double bond, with £ax
AOS. The results of present work present direct evidence that
allene oxides generated from hydroperoxides with (E,E) con-
jugated diene system are e¡ectively converted into trans-cyclo-
pentenones. Thus, the formation of trans-cyclopentenones
during both ‘albumin induced cyclization’ [21] and cyclization
of a complex 20:4 allene oxide [23] is, apparently, explained
by cis-trans double bond isomerization (Fig. 2, conversion of
3a into 3b).
Allene oxide annulation into cyclopentenones could be only
spontaneous under incubation conditions used in present
work. The rules of orbital symmetry conservation predict
the conrotatory electrocyclization for pericyclic pentadienyl
cation. Thus, the allene oxides formed from (Z,E) HPODs
should undergo annulation into cis-cyclopentenones. The ob-
tained results demonstrate that in fact they produce only small
quantities of trans-cyclopentenones. The inability of allene
oxides formed from (Z,E) HPODs to form cis-cyclopente-
nones is, apparently, explained by sterical factor. Pericyclic
pentadienyl cation 4a (Fig. 2) is essential for electrocyclization
[24]. Its formation through the conformation transition of
zwitterion 3a is disabled due to sterical hindrance caused by
cis-con¢guration of double bond (Fig. 2). Allene oxides
formed from all-(E) HPODs, being free of this sterical hin-
drance, easily form pericyclic cation 4b, which undergoes an-
nulation into racemic trans-cyclopentenones (Fig. 2). This ob-
served stereospeci¢city of cyclization is fully consistent with
the rules of orbital symmetry conservation and with published
experimental data for synthetic analogues of natural allene
oxides [25]. Small yields of trans-cyclopentenones from (Z,E)
HPODs are, apparently, explained by partial cis-trans double
bond isomerization within the pentadienyl cation (conversion
of 3a into 3b, Fig. 2).
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